Continuos Terlipressin Infusion in Septic Shock
NCT01697410 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000
Last updated 2014-12-30
Summary
The purpose of this study is to evaluate the efficacy of terlipressin for treating septic shock.
Conditions
- Septic Shock
Interventions
- DRUG
-
Terlipressin
continuous infusion of terlipressin (0.66ug/min-2.66ug/min) ,dosage modified acorrding to blood pressure
- DRUG
-
Norepinephrine
continuous infusion with dose 7.5ug/min-30ug/min,modified acorrding to blood pressure
Sponsors & Collaborators
-
Guangdong Province, Department of Science and Technology
collaborator OTHER_GOV -
Second Affiliated Hospital, Sun Yat-Sen University
collaborator OTHER -
Sixth Affiliated Hospital, Sun Yat-sen University
collaborator OTHER -
Chinese PLA General Hospital
collaborator OTHER -
Beijing 302 Hospital
collaborator OTHER -
Shanghai Changzheng Hospital
collaborator OTHER -
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
collaborator OTHER -
Xiangya Hospital of Central South University
collaborator OTHER -
Anhui Provincial Hospital
collaborator OTHER_GOV -
The First Affiliated Hospital of Bengbu Medical University
collaborator OTHER -
Guangxi Medical University
collaborator OTHER -
Jinling Hospital, China
collaborator OTHER -
West China Hospital
collaborator OTHER -
Hainan People's Hospital
collaborator OTHER -
Xi'an Jiaotong University
collaborator OTHER -
China Medical University, China
collaborator OTHER -
First People's Hospital of Foshan
collaborator OTHER -
ZhuHai Hospital
collaborator OTHER -
First Affiliated Hospital, Sun Yat-Sen University
lead OTHER
Principal Investigators
-
Guan XiangDong, doctor · first affiliated hospital SunYetSen university
-
liu ZiMeng, M.D · first affiliated hospital ,SunYetSen university
-
Si Xiang, M.D. · first affiliated hospital ,SunYetSen university
-
Chen Juan, M.D. · first affiliated hospital ,SunYetSen university
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-01-31
- Primary Completion
- 2016-01-31
- Completion
- 2016-01-31
Countries
- China
Study Locations
More Related Trials
-
Early Use of Norepinephrine in Septic Shock Resuscitation
NCT01945983 ·Status: COMPLETED ·Phase: NA
-
Clinical Research on Shenfu Injection in Septic Patients
NCT06157320 ·Status: RECRUITING ·Phase: NA
-
Strategy of Early Improvement of Tissue Oxygenation Decrease the Mortality of Severe Sepsis and Septic Shock
NCT01310790 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety and Effect of STC314 Injection Continuous Infusion in Subjects With Acute Respiratory Distress Syndrome
NCT05000671 ·Status: UNKNOWN ·Phase: PHASE1
-
Continuous Infusion of Terlipressin in Septic Shock
NCT00481572 ·Status: COMPLETED ·Phase: PHASE2
-
Systematic Adjunction of Vasopressine in Septic Shock
NCT07052084 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Hypotension in the Weaning From Vasopressor Drugs
NCT05506319 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Glucocorticoid Combined With Vitamin C and Vitamin B1 on Microcirculation in Severe Septic Shock
NCT03821714 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Early Association of Terlipressin and Norepinephrine During Septic Shock; the TerliNor Study
NCT03336814 ·Status: UNKNOWN ·Phase: PHASE4
-
Anisodamine Critically Ill SeptIc Shock
NCT02442440 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of Methylene Blue in the Treatment of Severe Septic Shock
NCT06481410 ·Status: RECRUITING ·Phase: NA
-
Evaluating the Effect of Chronic Antihypertensive Therapy on Vasopressor Dosing in Septic Shock
NCT02884011 ·Status: COMPLETED
-
Temperature Gradients for Sepsis Severity and Fluid Resuscitation
NCT04068298 ·Status: UNKNOWN
-
Shenfu Injection Improves Arterial Vascular Reactivity
NCT03749525 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Protocol-driven Hemodynamic Support for Patients With Septic Shock
NCT00335907 ·Status: UNKNOWN ·Phase: NA
-
Study on the Construction and Application of Early Warning Model of Sepsis in Critically Ill Patients
NCT06904001 ·Status: ENROLLING_BY_INVITATION
-
Intravenous Metoprolol in Septic Shock
NCT06592547 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Esmolol on Clinical Prognosis of Patients With Severe Sepsis
NCT02794025 ·Status: COMPLETED ·Phase: NA
-
Vasopressin Hemodynamic Response as a Septic Shock Subphenotype Indicator
NCT06426407 ·Status: TERMINATED
-
The Effect of Early Use of Methylene Blue on Hemodynamics in Septic Shock
NCT04970602 ·Status: UNKNOWN ·Phase: NA
-
Initiation of Hydrocortisone for the Treatment of Septic Shock
NCT02580240 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial Comparing Noradrenaline (NA) Plus Placebo Versus Noradrenaline Plus Terlipressin (TP) in Septic Shock
NCT05207280 ·Status: UNKNOWN ·Phase: PHASE3
-
The Effect of Increasing the Mean Arterial Pressure on the Microcirculation and the Prognosis of Patients With Septic Shock
NCT04136080 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Bolus Versus Continuous Infusion of Terlipressin Cirrhotic Patients With Septic Shock.
NCT04819568 ·Status: UNKNOWN ·Phase: NA
-
Effect of Dexmedetomidine vs Esmolol or Placebo on Cerebral Hemodynamics in Septic Shock
NCT06169475 ·Status: COMPLETED ·Phase: NA